Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “QTc Evaluation”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05906732
What this trial is testing

Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).

Who this might be right for
Long QT Syndrome
Thryv Therapeutics, Inc. 42
Early research (Phase 1)Study completedNCT02027454
What this trial is testing

Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 42
Early research (Phase 1)Not Yet RecruitingNCT07470177
What this trial is testing

Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

Who this might be right for
ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare 24
Early research (Phase 1)Ended earlyNCT05668936
What this trial is testing

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 31
Early research (Phase 1)Study completedNCT03822520
What this trial is testing

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

Who this might be right for
Qt Interval, Variation in
Samsung Medical Center 28
Early research (Phase 1)Study completedNCT01738451
What this trial is testing

Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive Tumors

Who this might be right for
Cancer
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT00789568
What this trial is testing

Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects

Who this might be right for
Phenylketonuria
BioMarin Pharmaceutical 56
Early research (Phase 1)Study completedNCT03510663
What this trial is testing

Phase I Study of OPC-61815

Who this might be right for
Congestive Heart Failure
Otsuka Pharmaceutical Co., Ltd. 48
Early research (Phase 1)UnknownNCT06543459
What this trial is testing

To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Wuhan Createrna Science and Technology Co., Ltd 16
Early research (Phase 1)Study completedNCT00861029
What this trial is testing

VEG111485: A QTc Study of Pazopanib

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 2
Early research (Phase 1)Study completedNCT06772246
What this trial is testing

Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate

Who this might be right for
Healthy Subjects
Daiichi Sankyo 70
Early research (Phase 1)Study completedNCT06837155
What this trial is testing

A QT/QTc Evaluation Study of TS-172 in Healthy Adult Subjects

Who this might be right for
Healthy Volunteers
Taisho Pharmaceutical Co., Ltd. 52
Early research (Phase 1)Study completedNCT01487135
What this trial is testing

Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects

Who this might be right for
Healthy SubjectsCardiac Repolarization
FORUM Pharmaceuticals Inc 60
Not applicableStudy completedNCT05623397
What this trial is testing

A Deep Learning Method to Evaluate QT on Ribociclib

Who this might be right for
Breast CancerRibociclib
CMC Ambroise Paré 70
Early research (Phase 1)UnknownNCT06473948
What this trial is testing

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Who this might be right for
Solid Tumor, Adult
Jemincare 27
Early research (Phase 1)Study completedNCT07422298
What this trial is testing

Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 32
Early research (Phase 1)Study completedNCT03958123
What this trial is testing

Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects

Who this might be right for
Prolonged QTc IntervalPharmacokinetic
Tris Pharma, Inc. 171
Early research (Phase 1)Study completedNCT00199225
What this trial is testing

Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers

Who this might be right for
Human Experimentation (Human Volunteers)
J. Uriach and Company 160
Early research (Phase 1)Study completedNCT02293148
What this trial is testing

Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers

Who this might be right for
Anaemia
GlaxoSmithKline 61
Early research (Phase 1)Study completedNCT01844583
What this trial is testing

Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

Who this might be right for
Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 55
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation